| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.28 | 0.03 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.03 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.04 |